European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications – actinic keratoses, Bowen's disease and basal cell carcinomasC.A. Morton, Lasse R. Braathen, Sigrid Karrer et al.|Journal of the European Academy of Dermatology and Venereology|2019Cited by 204
European Dermatology Forum Guidelines on topical photodynamic therapyC.A. Morton, Lasse R. Braathen, Rolf‐Markus Szeimies et al.|European Journal of Dermatology|2015Cited by 158
European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 2: emerging indications – field cancerization, photorejuvenation and inflammatory/infective dermatosesC.A. Morton, Lasse R. Braathen, Rolf‐Markus Szeimies et al.|Journal of the European Academy of Dermatology and Venereology|2019Cited by 152
LBA47 Primary analysis of phase II results for cemiplimab in patients (pts) with locally advanced basal cell carcinoma (laBCC) who progress on or are intolerant to hedgehog inhibitors (HHIs)Alexander Stratigos, M.G. Fury, Aleksandar Sekulić et al.|Annals of Oncology|2020Cited by 14